ARA-290

An EPO-derived peptide studied for nerve pain, without the red blood cell effect.

What it is

ARA-290 is a small peptide modelled on part of erythropoietin.

How it works

It targets the innate repair receptor linked to tissue protection.

What it is researched for

• Small fibre neuropathy
• Sarcoidosis symptoms

Research status

Investigational. Not approved.

What to watch for

• Limited trial data

Storage

Lyophilised powder keeps in the freezer or fridge, away from light. Once mixed with bacteriostatic water, keep it refrigerated and use it within about four weeks.

Common questions

Is ARA-290 approved for human use?

Investigational. Not approved.

Where can I read the research on ARA-290?

Use the PubMed, Europe PMC and clinical trials buttons on this page. They run a live search for ARA-290, so you see what is published today.

Educational reference only, not medical advice.